Zoetis to Participate in the Jefferies Global Healthcare Conference in London

Solid Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference

CHARLESTOWN, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the 'Company” or 'Solid”), a life sciences company developing precision genetic...

Zoetis to Participate in the Jefferies Global Healthcare Conference in London

PARSIPPANY, N.J.--(BUSINESS WIRE)--Nov 10, 2026-

Beacon Therapeutics to Participate in Jefferies 2026 Global Healthcare Conference in London - Beacon Therapeutics

Related posts: Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona’s Patented AAV204 Capsid for Select Ophthalmology Indications Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer Beacon Therapeutics Announces Positive Interim 9+ Month Results from DAWN Trial and 36-Month […]

Teleflex to Present at the Jefferies Global Healthcare Conference in London

WAYNE, Pa.--(BUSINESS WIRE)--Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 12:00 p.m. (GMT). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at telefle. About Teleflex Incorporated As a more...

Compass Pathways to Participate in Jefferies Global Healthcare Conference on November 18th and 19th – Novumpr

LONDON & JERSEY CITY, N.J.–(BUSINESS WIRE)– Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the Jefferies Global Healthcare Conference on November 18 and 19, 2026 and will participate in a fireside chat on November 18 at 9:00am […]

Hansa Biopharma to participate in Jefferies Global Healthcare Conference in London

Lund, Sweden, November 10, 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that Renée Aguiar-Lucander, CEO, Hansa Biopharma, will participate in a fireside chat with Farzin Haque, Biotechnology Equity Research Analyst, Jefferies, at the Jefferies Global Healthcare Conference in London, on Tuesday 17 November, at 14:00-14:25 GMT / 09:00-09:25 EST. Hansa Biopharma COO […]